PIOGLITAZONE ADJUNCTIVE THERAPY FOR DEPRESSIVE EPISODE OF BIPOLAR DISORDER: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Atefeh Zeinoddini(Roozbeh Hospital), Shahin Akhondzadeh(Arak University of Medical Sciences), Maryam Sorayani(Tehran University of Medical Sciences), Ali Ghaleiha(Hamedan University of Medical Sciences), Mehdi Farokhnia(National Institutes of Health), Elmira Hassanzadeh(Roozbeh Hospital), Samrand Salimi(Tehran University of Medical Sciences), Mohammad Arbabi(Roozbeh Hospital)
Cited by 107
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
|Clinical Neuropharmacology|2013|154
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151